Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.24.1.u1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets    
Cash and cash equivalents $ 107,924 $ 116,854
Accounts receivable, net of allowance for expected credit losses ($271 and $360, respectively) 21,493 24,059
Inventory 23,792 26,773
Prepaid expenses 3,328 2,756
Other current assets 1,733 2,022
Total current assets 158,270 172,464
Property and equipment, net 17,893 17,713
Intangible assets, net 15,924 17,128
Right-of-use assets 35,809 36,884
Other assets 3,734 3,763
Total assets 231,630 247,952
Current liabilities    
Accounts payable 11,877 13,235
Accrued expenses 12,451 9,840
Litigation Judgment Payable 17,300 0
Deferred revenue 9,609 8,779
Lease liabilities 7,316 7,368
Other current liabilities 1,500 1,526
Total current liabilities 60,053 40,748
Long-term deferred revenue 5,457 6,083
Contingent earnout liability 1,540 1,379
Long-term lease liabilities 34,647 35,771
Other liabilities 2,030 2,361
Total liabilities 103,727 86,342
Commitments and contingencies (Note 15)
Stockholders' equity    
Common stock, $0.0001 par value; 1,000,000,000 shares authorized at March 31, 2024 and December 31, 2023; 199,399,503 and 198,581,263 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively 19 19
Additional paid-in capital 369,561 366,281
Accumulated deficit (240,610) (204,664)
Accumulated other comprehensive (loss) income (1,067) (26)
Total stockholders' equity 127,903 161,610
Total liabilities and stockholders' equity $ 231,630 $ 247,952